What is CAPL's health score?

CrossAmerica Partners LP (CAPL) has a TradeApes health score of 50 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is CAPL's estimated fair value?

Based on our 5-year discounted cash flow model, CrossAmerica Partners LP's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is CAPL undervalued or overvalued?

Our model currently rates CAPL as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for CAPL... Refresh in a moment for the full analysis.

CrossAmerica Partners LP (CAPL)

Industrials Overvalued low mixed

$21.89

Updated: 2026-06-04

TradeApes Score

Financial Strength

25 Stressed

Operating Trend

55 Mixed

Relative Value

55 Mixed

Capital Allocation

55 Mixed

Risk

80 Strong

Key Findings

+ High FCF yield — above 7%, strong cash return relative to price paid

Unlock Full Report →

− High leverage — net debt/EBITDA between 3× and 5×

Unlock Full Report →

1 free score card remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.